Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

generic levitra
Govt says Ambanis apportioning public property
The two-month-long arguments in the legal dispute on gas supply between RIL and RNRL ended today, with the central government’s counsel firing salvoes at both the warring Ambani brothers for apportioning shares in public property.

payday loans canada
PC shipments to grow by 12.6% in 2010
Accelerating mobile PC shipments will drive the worldwide PC market to grow again, according to Gartner Inc, an information technology research and advisory company ‘s preliminary fourth-quarter forecast. In 2010, PC shipments are projected to reach 336.6 million units, a 12.6 per cent increase over 2009.

News of the day

Should RBI raise interest rates?
- Oil imports rise first time in over a year - 2010 set to be year of indices trading - Crisil to research illiquid stocks to help investors - "Indian regulatory regime has brought us a world of good" - Global crisis pinches FDI purse in 2009 - Experts debate rollback of lenient policy
Online Business

Govt stays suspension on Natco's Albupax licence

Government of India has stayed suspension of Natco Pharma"s Albupax manufacturing (product) licence. Albupax is a nanotechnology based drug and is the first generic version of the international brand Abraxane of Abraxis Bioscience Inc, USA. Albupax consists of Paclitaxel in an albumin-bound nanoparticle form and is used to treat breast cancer. - Natco Pharma, Apollo Hospitals, Sundram Fasteners & Emami Q2 result - Natco to release 1 mn doses of H1N1 drug - Natco to release 1 mn Natflu doses by Oct end - Natco Pharma launches anti-swine flu drug, Natflu - Natco stops production of breast cancer drug on liver concerns - Natco Pharma FY09 net rises 8.5% at Rs 44 cr Drugs Controller General of India (DCGI) had suspended Natco Pharma"s manufacturing license allegedly for not passing the test measuring endotoxin levels. Later, Natco Pharma appealed under the Drugs and Cosmetics Rules against the suspension order. Natco"s plea said an appropriate test method needs to be employed to evaluate nanotechnology based protein-bound formulations as the testing method used for such formulations are highly complex and variable. Natco would soon announce the future plans.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009